Turnstone Biologics Corp (TSBX)

[jondoeuk]

60% RIF (cash into 2026) https://www.oncologypipeline.com/apexonco/no-easy-ride-turnstone

[Stock Shakers]

https://www.tipranks.com/stocks/tsbx/forecast

[Monksdream]

TSBX new 52+week low

[jondoeuk]

I assume (rightly or wrongly) it is down as they were supposed to have shared data on ~20-30 patients. There was also no conference call and they cut two indications (I agree with melanoma). Data shows promise, but you have to show the market more than that.

https://finance.yahoo.com/news/turnstone-biologics-corp-reports-positive-200100662.html

[Monksdream]

TSBX under $3

[Monksdream]

TSBX under $3

[stock1ace1]

$3.02

[stock1ace1]

$2.94 buys coming in

[stock1ace1]

Tsbx -> We remain on track and plan to provide a TIDAL-01 clinical update mid-year in connection with our next quarterly financial results.”

[stock1ace1]

$3.00s (200ma break) #Bullish

[stock1ace1]

Tsbx $2.99 Pending data look at chart -> https://schrts.co/JiDydKgr

[Monksdream]

TSBX under $3

[jondoeuk]

CEO saying data in July-August.

[Monksdream]

TSBX under $3

[Laster]

Nice biotech company. Looks like it wants to break out past $3.50.
I think it has a lot more to run,
JMO.

[TrendTrade2016]

TSBX....here we go...monster bio

[TrendTrade2016]

TSBX...MONSTER BIO BEAST IS READY TO BLOW UP

[jondoeuk]

What was?

[Awl416]

That was quick

[jondoeuk]

New #JITC article: Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients https://t.co/jORw8004JP @JohnEMullinaxMD pic.twitter.com/a7RR2K5MrQ

— Journal for ImmunoTherapy of Cancer (@jitcancer) October 6, 2023

[jondoeuk]

Upcoming https://finance.yahoo.com/news/turnstone-biologics-present-preclinical-data-100000133.html